SCHEMBL30990437

SCHEMBL30990437

CCCC[Sn](CCCC)(CCCC)c1cn(C2CCN(C(=O)OC(C)(C)C)CC2)cn1

nearest known ligand 0.42

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ GPR119 Q8TDV5 12/20 0.42
▸ FAAH O00519 1/20 0.41
▸ HCAR1 Q9BXC0 1/20 0.41
▸ JAK2 O60674 1/20 0.40
▸ JAK1 P23458 1/20 0.40
▸ TYK2 P29597 1/20 0.40
▸ JAK3 P52333 1/20 0.40
▸ PDE4A P27815 1/20 0.40
▸ PDE4B Q07343 1/20 0.40
▸ PDE4C Q08493 1/20 0.40
▸ PDE4D Q08499 1/20 0.40
▸ CTSD P07339 1/20 0.39
▸ CTSE P14091 1/20 0.39
▸ BACE1 P56817 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25214363 0.82 PDE4D (0.41) GPR119FAAHPDE4APDE4BPDE4C
SCHEMBL947678 0.78 GPR119 (0.50) GPR119HCAR1JAK2JAK1TYK2
SCHEMBL25218107 0.78 GPR119 (0.41) GPR119FAAHPDE4APDE4BPDE4C
SCHEMBL15525325 0.78 DDB1 (0.48) GPR119JAK2JAK3PDE4APDE4B
SCHEMBL25626286 0.78 GPR119 (0.47) GPR119FAAHHCAR1JAK2JAK1
SCHEMBL27460187 0.77 GPR119 (0.49) GPR119HCAR1JAK2JAK1TYK2
SCHEMBL1799144 0.77 CTSD (0.49) GPR119HCAR1CTSDCTSEBACE1
SCHEMBL31591369 0.77 GPR119 (0.32) GPR119FAAH
SCHEMBL1555054 0.76 GPR119 (0.48) GPR119HCAR1JAK2JAK1TYK2
SCHEMBL8623093 0.76 GPR119 (0.49) GPR119HCAR1JAK2JAK1TYK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4665720-A2 ISOINDOLINONE GLUTARIMIDE AND PHENYL GLUTARIMIDE ANALOGS AS DEGRADERS OF RET KINASE Bristol-Myers Squibb Company (US) 2025-12-24 — — EP disclosed
WO-2024173832-A2 ISOINDOLINONE GLUTARIMIDE AND PHENYL GLUTARIMIDE ANALOGS AS DEGRADERS OF RET KINASE BRISTOL-MYERS SQUIBB COMPANY (US) 2024-08-22 — — WO disclosed
Send feedback